16 March 2017 We are delighted Professor Jerome Sarris commenced his role this year with NICM as our new Deputy Director, a role critical in fulfilling our Institute's mission. In his first few months, Professor Sarris has met with many of NICM's stakeholders from academics, government, industry, associations and the healthcare sector.
10 March 2017 NICM Researchers, students and staff today participated in "March into Yellow" - a day designed to bring awareness to endometriosis. March into Yellow is a worldwide event supported by Endometriosis Australia.
3 March 2017 A profession-specific annual report summary that looks into the work of the Chinese Medicine Board of Australia over the year to 30 June 2016 has been published. The report draws on data from the 2015/16 annual report by AHPRA and the National Boards.
21 December 2016 As the year draws to a close, we would like to take the opportunity to thank our colleagues and stakeholders who have worked with us towards our vision. Next year marks a historical occasion for NICM, celebrating its 10 year anniversary and a year of further growth and development for the Institute.
30 November 2016 NICM is pleased to announce the appointment of Dr Carolyn Ee as the Jacka Foundation Senior Research Fellow. Professor Alan Bensoussan, NICM Director said the newly created position will help increase the integration of well-evidenced complementary medicine into routine healthcare with formal collaborations with hospitals and health centres.
30 November 2016 NICM’s annual caucus meeting provided an important opportunity to discuss the Institute's five strategic goals that underpin Institute’s vision and mission, expanding research programs, healthy hearts, healthy minds, healthy women, healthy lives post-cancer, and hear from fellow expert speakers.
26 October 2016 Researchers from NICM, Cardiac Health Institute, and Centre for Evidence-Based Chinese Medicine at Beijing University of Chinese Medicine are investigating the health benefits of Tai Chi for heart disease, hypertension and quality of life in an international clinical trial currently underway in Sydney and Beijing.
21 October 2016 The Australian Government’s response to the Review of Medicines and Medical Devices Regulation marked a key milestone in NICM’s work to secure regulatory reform that provides greater incentives for industry investment in research and development, and has been well received by the complementary medicine sector since its release in September.
21 October 2016 An industry partner program between NICM, Western Sydney University and Beijing Tong Ren Tang Chinese Medicine Corporation Ltd. is now underway to investigate safeties of possible new Chinese medicine ingredients and evidence to support use in Australia and promote the further research and development of therapeutic products.